Carnegie Mellon University
Why Carnegie Mellon for Science: Ready to Hit the Ground Running

Why Carnegie Mellon for Science

< previous | The First Year Experience >

D.J. Kleinbaum (right) and Brian Frezza in Emerald Therapeutics lab

Professional Preparation

Whether they go to graduate school, medical school or a job in industry, students leave MCS as professionals. They are adept at communicating to a broad audience, can work in diverse and multidisciplinary teams and are aware of the global context of their work.

Above: Emerald Therapeutics, founded by alumni D.J. Kleinbaum (right) and Brian Frezza, applies the cloud computing model to expensive and often tedious drug discovery research, making the process faster and cheaper. Kleinbaum and Frezza return to Carnegie Mellon every year to recruit students to join their multi-disciplinary team at Emerald Therapeutics. (Photograph by Ike Edeani for Bloomberg Businessweek

< previous | The First Year Experience >